A combined transcriptome and proteome analysis of mouse radiation-induced AMLs using two primary AMLs, cell lines from these primaries, another cell line and its in vivo passage is reported. Compared to haematopoietic progenitor and stem cells (HPSC), over 5000 transcriptome alterations were identified, 2600 present in all materials. 55 and 3 alterations were detected in the proteomes of the cell lines and primary/in vivo passage material respectively, with one common to all materials. In cell lines, approximately 50% of the transcriptome changes are related to adaptation to cell culture, and in the proteome this proportion was higher. An AML 'signature' of 17 genes/proteins commonly deregulated in primary AMLs and cell lines compar...
Acknowledgements: This work was funded by the following NIH/NCI/NCTN grant awards: RO1CA190661, R01C...
Inappropriate localization of proteins can interfere with normal cellular function and drive tumor d...
Acute myeloid leukemia (AML) is an aggressive blood cancer with a poor prognosis. We report a compre...
Myeloid leukemia (ML) is one of the major health concerns from exposure to radiation. However, the r...
Studies of r-AML susceptible CBA/H and r-AML resistant C57BL/6 inbred mice have provided an animal m...
OBJECTIVE: High-dose radiation exposure induces acute myeloid leukemia (AML) in C3H mice, most of wh...
Because protein function regulates the phenotypic characteristics of cancer, a functional proteomic ...
2010 Spring.Includes bibliographic references.Covers not scanned.Print version deaccessioned 2022.Ac...
Aim: Although acute myelogenous leukemia (AML) arising after radiation exposure is considered to be ...
The accumulation of mistakes in the DNA of healthy blood (stem) cells can result in acute myeloid le...
Acute myeloid leukemia (AML) is believed to arise from leukemic stem-like cells (LSC) making underst...
Acute myeloid leukemia (AML) is an aggressive bone marrow malignancy, and non-leukemic stromal cells...
CBA/H inbred mice are susceptible to radiation-induced acute myeloid leukaemia (r-AML) while C57BL/6...
Acute myeloid leukemia (AML) is believed to arise from leukemic stem-like cells (LSC) making underst...
Myeloid leukemia (ML) is one of the major health concerns from exposure to radiation. However, the r...
Acknowledgements: This work was funded by the following NIH/NCI/NCTN grant awards: RO1CA190661, R01C...
Inappropriate localization of proteins can interfere with normal cellular function and drive tumor d...
Acute myeloid leukemia (AML) is an aggressive blood cancer with a poor prognosis. We report a compre...
Myeloid leukemia (ML) is one of the major health concerns from exposure to radiation. However, the r...
Studies of r-AML susceptible CBA/H and r-AML resistant C57BL/6 inbred mice have provided an animal m...
OBJECTIVE: High-dose radiation exposure induces acute myeloid leukemia (AML) in C3H mice, most of wh...
Because protein function regulates the phenotypic characteristics of cancer, a functional proteomic ...
2010 Spring.Includes bibliographic references.Covers not scanned.Print version deaccessioned 2022.Ac...
Aim: Although acute myelogenous leukemia (AML) arising after radiation exposure is considered to be ...
The accumulation of mistakes in the DNA of healthy blood (stem) cells can result in acute myeloid le...
Acute myeloid leukemia (AML) is believed to arise from leukemic stem-like cells (LSC) making underst...
Acute myeloid leukemia (AML) is an aggressive bone marrow malignancy, and non-leukemic stromal cells...
CBA/H inbred mice are susceptible to radiation-induced acute myeloid leukaemia (r-AML) while C57BL/6...
Acute myeloid leukemia (AML) is believed to arise from leukemic stem-like cells (LSC) making underst...
Myeloid leukemia (ML) is one of the major health concerns from exposure to radiation. However, the r...
Acknowledgements: This work was funded by the following NIH/NCI/NCTN grant awards: RO1CA190661, R01C...
Inappropriate localization of proteins can interfere with normal cellular function and drive tumor d...
Acute myeloid leukemia (AML) is an aggressive blood cancer with a poor prognosis. We report a compre...